BNF 83 (British National Formulary) March 2022

Product Information

Clarithromycin [update to include dosing for prevention of invasive group A streptococcal infection in children from 6 months old and adults]. If you’re a UK-based individual undertaking work or training for the NHS, you can register for access to BNF content on MedicinesComplete. As a registered NHS user, you’ll get single user access to BNF and BNF for Children content on MedicinesComplete for 365 days. Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure [MHRA/CHM advice] (see advice in Aromatic inhalations, cough preparations and systemic nasal decongestants).

Pharmacology: Citing references - University of Reading Pharmacology: Citing references - University of Reading

Aminoglycosides: pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing (advice in relevant monographs; see example in gentamicin). Vaccines update [classifications changed to Vaccines, live or Vaccines, inactivated and non-replicating]. A significant investment from National Institute for Health and Care Excellence (NICE) ensures that, with our partners BMJ Group and Royal College of Paediatrics and Child Health, we support NHS health professionals in the UK with unlimited access to BNF content online through MedicinesComplete, via the BNF + BNFC app and in print. Vaccination, general principles: updated guidance on vaccination during pregnancy and breast-feeding.

Azithromycin [update to dosing for uncomplicated non-gonococcal urethritis in children aged 12 to 17 years old]. The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care.The new edition (BNF 83) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines Related articles Independent, authoritative guidance on best practices that enables you to select safe and effective medications Vaccines update: restructure of Influenza vaccine monograph—creation of monographs for influenza vaccine (live) and influenza vaccine (inactivated).

BNF Publications Online Access British National Formulary | BNF Publications

Drugs that cause hepatotoxicity, drugs with CNS depressant effects, and drugs that increase serum potassium: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions. Specialist drug” monographs within BNF Publications: identification and reduced level of detail, see How to use BNF Publications online.To read this ebook on a mobile device (phone or tablet) you'll need to install one of these free apps: Mental Health and Criminal Justice Bridging the Gap by J. Steven Lamberti,Robert L. Weisman,Vivek Furtado This update contains 5 significant changes, 2 new monographs, 2 new preparations, 4 deleted monographs and 2 deleted preparations. This update contains 12 significant changes, 4 dose changes, 1 classification change, 5 new monographs, 1 new preparation, 1 deleted monograph and 1 deleted preparation.

BNF 83 (British National Formulary) March 2022 - Pharmacy Books BNF 83 (British National Formulary) March 2022 - Pharmacy Books

The new edition (BNF 83) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.Direct-acting oral anticoagulants (DOACs): reminder of dose adjustments in patients with renal impairment [MHRA/CHM advice] (advice in apixaban, dabigatran etexilate, edoxaban, and rivaroxaban; see example in dabigatran etexilate). The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some recent key changes that have been made to BNF content. Selective serotonin re-uptake inhibitors: breast-feeding advice for all drugs in class and individual drug monographs updated (see examples in fluoxetine and sertraline). Calcium chloride, calcium gluconate: potential risk of underdosing with calcium gluconate in severe hyperkalaemia [MHRA/CHM advice] (advice in calcium gluconate). Tranexamic acid [update to dosing for prevention and treatment of significant haemorrhage following major trauma].